Liabilities, Current of Kuvatris Therapeutics, Inc. from 31 Dec 2021 to 30 Sep 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Kuvatris Therapeutics, Inc. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2021 to 30 Sep 2024.
Kuvatris Therapeutics, Inc. Liabilities, Current for the quarter ending 30 Sep 2024 was $2,251,950, a 31% decline year-over-year.
Source SEC data: View on sec.gov

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

Kuvatris Therapeutics, Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	$2,251,950	-$1,018,546	-31%	30 Sep 2024	10-Q	14 Jan 2026	2024	Q3
Q2 2024	$2,107,231	-$317,941	-13%	30 Jun 2024	10-Q	20 Sep 2024	2024	Q2
Q1 2024	$1,203,095	-$596,306	-33%	31 Mar 2024	10-Q	13 May 2024	2024	Q1
Q4 2023	$1,795,332	-$300,186	-14%	31 Dec 2023	10-Q	14 Jan 2026	2024	Q3
Q3 2023	$3,270,496	-$320,973	-8.9%	30 Sep 2023	10-Q	16 Nov 2023	2023	Q3
Q2 2023	$2,425,172	-$6,027,562	-71%	30 Jun 2023	10-Q	09 Aug 2023	2023	Q2
Q1 2023	$1,799,401			31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$2,095,518	-$8,662,211	-81%	31 Dec 2022	10-K	11 Mar 2024	2023	FY
Q3 2022	$3,591,469			30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$8,452,734			30 Jun 2022	10-Q	30 Sep 2022	2022	Q2
Q4 2021	$10,757,729			31 Dec 2021	10-K	30 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.